- Peptide Therapeutics, OraVax will merge for greater mass
- Baxter, Peptide Therapeutics develop vaccines; terminated
- Acambis signs marketing deal for Cangene's smallpox vaccine
- Intercell licenses VaccGen's encephalitis vaccine candidate
- British Biotech buys Vernalis for £47.3m
- British Biotech merges with RiboTargets
- Celltech acquires OGS
- Cell Therapeutics acquires Novuspharma
- Chiron buys PowderJect for £542mm
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.